Ning et al. revealed that CXCL8 regulated OXA-resistance of CRC cell lines by binding to CXCR2 and activating the AKT/MAPK/NF-κB signaling pathway [11]. This evidence concerns the gene CXCR2 and colorectal carcinoma.